bioRxiv Science⌕ Search

Biology subjects

Lovell, N. H.

Publications and source records attributed to Lovell, N. H..

3 recordsLinked to original sources

Validation of a multiscale Hill-type actuator against comprehensive benchmarks of motor unit and muscle force measurements

Computational Hill-type muscle models are widely used to simulate muscle force production because of their efficiency and physiological interpretability. However, their formulation relies on limiting assumptions, including debated multiscale simplifications, a simplified excitation-activation dynamics and an inability to capture slow and fast fibres. Moreover, existing Hill-type models remain insufficiently validated across physiological scales, fibre types, and contraction modes. We addressed these limitations by developing a multiscale fibre-type specific Hill-type neuromuscular actuator with mechanistic excitation-activation dynamics and systematically validated it against comprehensive experimental benchmarks. The model built upon a previously proposed motoneuron-driven actuator incorporating calcium-kinetics-based activation dynamics. The excitation-activation formulation was further refined to strengthen its physiological basis, while the contraction dynamics was extended by including an activation- and length-dependent force-velocity relationship, elastic tendon, passive elastic element, and the fibre-type-specific effects of yielding and sag. Validation was performed against four benchmark datasets spanning motor-unit and whole-muscle scales, including slow and fast fibres under both isometric and dynamic conditions. Experimental force traces were obtained from six muscles of rats and cats using a broad range of stimulation frequencies, muscle lengths, and imposed length changes, combining previous literature datasets with experiments performed ad hoc for this study. Overall, the model reproduced forces across all benchmark conditions, with mean absolute errors typically below 15% of the maximum isometric force, although larger errors were observed in specific submaximal and dynamic trials. The inclusion of physiologically based excitation-activation dynamics, together with yielding and sag, improved model performance under submaximal activation conditions. This study presents the first systematic validation of a single multiscale Hill-type neuromuscular actuator against comprehensive experimental motor unit and muscle force data, providing a benchmark framework for the development and assessment of future models. Author summarySkeletal muscles generate force through a complex sequence of events that links neural signals to muscle contraction. Because direct measurements are difficult to obtain, researchers often rely on computer models to investigate neuromuscular function and estimate muscle forces. However, most modelling approaches rely on simplifying assumptions about how force is generated across different biological scales, how muscles are activated, and how slow and fast muscle fibres behave. Moreover, they have not been validated against comprehensive experimental data. As a result, it remains unclear how accurately these models can reproduce muscle force across different physiological conditions. In this study, we established the first comprehensive set of experimental benchmarks spanning both motor-unit and whole-muscle scales, including slow and fast muscles under isometric and dynamic conditions. We used these benchmarks to validate a newly developed multiscale muscle model that explicitly represents the physiological pathway from neural stimulation to force production. The model incorporates experimentally based descriptions of calcium dynamics, activation, tendon elasticity, and fibre-type-specific contractile properties. We then compared simulated and experimental force responses across a wide range of stimulation frequencies, muscle lengths, and length-change conditions.

bioengineering↗

Comparative Analysis of Single-Nucleus and Single-Cell RNA Sequencing in Human Bone Marrow Mononuclear Cells: Methodological Insights and Trade-offs

Bone marrow mononuclear cells (BMMCs) are a heterogeneous pool of hematopoietic progenitors and mature immune cells that collectively sustain hematopoiesis and coordinate immune responses. The bone marrow serves not only as the primary site for blood cell production but also as a niche for various disorders, including blood cancers. Advances in single-cell RNA sequencing (scRNA-seq) and single-nucleus RNA sequencing (snRNA-seq) have significantly enhanced our understanding of the cellular biology and molecular dynamics within this complex microenvironment. The choice between these two approaches, however, is often shaped or constrained by the study design, such as research objectives, sample type, and preservation conditions. Consequently, methodological differences in library preparation and transcript capture efficiency can introduce systematic biases that complicate downstream analyses and interpretation, underscoring the need to identify and account for method-specific features. In this study, we conducted a comparative analysis of matched snRNA-seq and scRNA-seq datasets from 11 pairs of healthy donor bone marrow mononuclear cell samples, generated using the popular 10x Genomics platform. We evaluated method-specific biases using multiple quality metrics and compared cell type proportions and transcriptomic signatures captured by each approach. Integrative analysis of these datasets is feasible but not advisable due to systematic gene length biases that were observed between these approaches. Our results showed that despite inherent differences in library complexity, both protocols reliably captured all major cell types. This comparative analysis highlights intrinsic differences between snRNA-seq and scRNA-seq data, providing valuable insights into their respective advantages, limitations, and trade-offs. These findings can assist researchers in selecting the optimal method tailored to specific biological questions and sample characteristics, and also enable more method-aware data analysis and interpretation.

bioinformatics↗

Somatic point mutations are enriched in long non-coding RNAs with possible regulatory function in breast cancer

De novo somatic point mutations identified in breast cancer are predominantly non-coding and typically attributed to altered regulatory elements such as enhancers and promoters. However, while the non-coding RNAs (ncRNAs) form a large portion of the mammalian genome, their biological functions are mostly poorly characterized in cancers. In this study, using a newly developed tool, SomaGene, we reanalyze de novo somatic point mutations from the International Cancer Genome Consortium (ICGC) whole-genome sequencing data of 1,855 breast cancers. We identify 929 candidates of ncRNAs that are significantly and explicitly mutated in breast cancer samples. By integrating data from the ENCODE regulatory features and FANTOM5 expression atlas, we show that the candidate ncRNAs in breast cancer samples significantly enrich for active chromatin histone marks (1.9 times), CTCF binding sites (2.45 times), DNase accessibility (1.76 times), HMM predicted enhancers (2.26 times) and eQTL polymorphisms (1.77 times). Importantly, we show that the 929 ncRNAs contain a much higher level (3.64 times) of breast cancer-associated genome-wide association (GWAS) single nucleotide polymorphisms (SNPs) than genome-wide expectation. Such enrichment has not been seen with GWAS SNPs from other diseases. Using breast tissue related Hi-C data we then show that 82% of our candidate ncRNAs (1.9 times) significantly interact with the promoter of protein-coding genes, including previously known cancer-associated genes, suggesting the critical role for candidate ncRNA genes in activation of essential regulators of development and differentiation in breast cancer. We provide an extensive web-based resource (http://ncrna.ictic.sharif.edu), to communicate our results with the research community. Our list of breast cancer-specific ncRNA genes has the potential to provide a better understanding of the underlying genetic causes of breast cancer. Lastly, the tool developed in this study can be used in the analysis of somatic mutations in all cancers.

cancer biology↗